FDA APPROVES FIRST DRUG TO TREAT TARDIVE DYSKINESIA

FDA APPROVES FIRST DRUG TO TREAT TARDIVE DYSKINESIA

The U.S. Food and Drug Administration approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.  

Continúa leyendo